Acoltzin C, Lizama J, Lozoya J, Ariza H

Language: Spanish
References: 13
Page: 111-114
PDF size: 97.86 Kb.

ABSTRACT

Has the heart failure causes like: Specific cardiovascular disease as predisponent, and a desencadenant cause from the same disease, acute from no cardiac origin or from structural damage? Methodology: Four hundred patients with heart failure were studied with clinic, electrocardiogram and chest X ray. Some included pulmonary scanner, antistreptolysin, C-reactive protein, blood cultures and arterial gases. Results: Predisponent causes were: rheumatic heart disease (52.5%), ischemic artery disease (23.5%), systemic hypertensive heart disease (9.5%), cardiomyopathy (8.25%) and pulmonary hypertension (6.25%). There were desencadenant causes: from same the cardiac disease in 290 patients 72.5%, from associated pathology 9.25% and non responding ventricular dysfunction 18.25%. In the rheumatic heart disease the causes were: Atrial fibrillation, pulmonary embolism, rheumatic fever and infective endocarditis. In ischemic heart artery disease we found acute myocardial infarction, angor pectoris, arrhythmias and left ventricular aneurysm. In systemic hypertension the high blood pressure and cardiac arrhythmias were the acute factors. In cardiomyopathy: cardiac arrhythmias and pulmonary embolism. And in pulmonary hypertension: the acute bronchitis, cardiac arrhythmias and pulmonary distress. From no cardiac origin in 37 patients (9.25%): Pregnancy, digitalis intoxication, pneumoniae and gastroenteritis. Heart failure from cardiac structural damage in 73 patients (18.25%). Conclusion: There are causes predisponent and acute in heart failure.

REFERENCES

1. Kannel WB. Epidemiological aspects of heart failure. Cardiol Clin 198; 7(1): 1-91.

2. Consensus trial study group. Effects of enalapril on mortality in severe congestive heart failure. Result of the cooperative North Scandinavian enalapril survival study. N Engl J Med 1987; 316: 1429-35.

3. Guía resumida del tratamiento de la insuficiencia cardiaca publicada por el grupo de trabajo de la Organización Mundial de la Salud. Consejo de cardiología geriátrica para la formación en la insuficiencia cardiaca.

4. Kannel WB. Clinical misconceptions dispelled by epidemiology research. Circulation 1995; 92(11): 3350-60.

5. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Reart J 1991; 121: 1852-53.

6. Philbin EF, DiSalvo TG. Predicción de reingreso hospitalario por insuficiencia cardiaca. Desarrollo de una escala de valoración sencilla basada en datos administrativos. JAAC (ed. mex.) 1999; 8(6): 230-36.

7. Doba N, Tomiyama H, Nakayama T. Drugs, heart failure and quality of life: What are we achieving? What should we be trying to achieve? Drug Aging 1999; 14(3): 153-63.

8. Young JB. Contemporary management of patients with heart failure. Medical Clinics of North America 1995; 79(5): 1171-1190.

9. Feenstra J, Grobbee D, Reinme WJ, Stricker BHCH. Insuficiencia cardiaca causada por fármacos. JACC (ed. mex) 1999; 8(4): 141-150.

10. Dargie HJ, McMuray JJV. Diagnóstico y manejo de la insuficiencia cardiaca. BMJ 1994; 308: 321-328.

11. Kannel WB, D’Agostino RB, Silbershatz H, Belanger AJ, Wilson PW, Levy D. Profile for estimating risk of heart failure. Arch Intern Med 1999; 159(11): 1197-204.

12. Chen YT, Vaccarino V, Williams CS, Butler J, Berkmann LF, Krumholz HM. Risk factors of heart failure in the elderly. A prospective community based study. Am J Med 1999; 106: 605-12.

13. Navarro-Robles J, Necoechea-Alva JC. I Consenso Nacional de Insuficiencia Cardiaca. Rev Mex Cardiol 2000; 11(2): 234 y 239.